Overview

Fetal Hemoglobin Induction Treatment Metformin

Status:
Completed
Trial end date:
2020-07-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether metformin is effective in the treatment for sickle cell anemia (SCA).
Phase:
Early Phase 1
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
Pfizer
Treatments:
Hydroxyurea
Metformin